60 stories tagged with #biotech, in publish-time order across the WeSearch catalog. Tag pages update as new stories ingest.
⌘ RSS feed for this tag → or search "Biotech"
Stock Market Today: Nasdaq, Dow Sink As Chip Stocks Slide, Trump Warns; A Biotech Breaks Out (Live Coverage)
Designer babies. Self-improving AI. Are we ready for either?
How do we know when the world has changed? On June 1, a team of scientists published a preprint scientific paper claiming they had edited human embryonic DNA with more precision th…
Fifty years of modern biotech, and an appetite for change
This year marks roughly fifty years since the modern biotechnology era began — an era defined by recombinant DNA, monoclonal antibodies, genomics, and platform technologies once be…
Targeting US$610 billion longevity market, biotech firms race to reverse ageing
AI is transforming longevity as companies like METiS TechBio and Human Longevity use algorithms to combat ageing and predict health risks.…
4D Molecular Therapeutics, Inc. (FDMT) Presents at Jefferies Global Healthcare Conference 2026 Transcript
4D Molecular Therapeutics, Inc. (FDMT) Jefferies Global Healthcare Conference 2026 June 3, 2026 3:10 PM EDTCompany ParticipantsDavid Kirn - Co-Founder,...…
Denali Therapeutics Inc. (DNLI) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Denali Therapeutics Inc. (DNLI) Jefferies Global Healthcare Conference 2026 June 4, 2026 8:45 AM EDTCompany ParticipantsRyan Watts - Co-Founder, President,...…
Absci Corporation (ABSI) Presents at Jefferies Global Healthcare Conference 2026 Prepared Remarks Transcript
Absci Corporation (ABSI) Jefferies Global Healthcare Conference 2026 June 3, 2026 7:35 AM EDTCompany ParticipantsSean McClain - Founder, CEO, President...…
Tenaya Therapeutics, Inc. (TNYA) Presents at Jefferies Global Healthcare Conference 2026 Prepared Remarks Transcript
Tenaya Therapeutics, Inc. (TNYA) Jefferies Global Healthcare Conference 2026 June 4, 2026 3:10 PM EDTCompany ParticipantsFaraz Ali - CEO, Interim Principal...…
Caribou Biosciences, Inc. (CRBU) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Caribou Biosciences, Inc. (CRBU) Jefferies Global Healthcare Conference 2026 June 4, 2026 2:35 PM EDTCompany ParticipantsRachel Haurwitz - Co-Founder, CEO,...…
Edgewise: 'Buy' On Muscular Dystrophy Program Sale And EDG-7500 Advancement
Edgewise Therapeutics (EWTX) stays a Buy after its $2.65B Servier deal funds EDG-7500 for HCM with key Q2 2026 data. Read here for more analysis.…
AI leaders call for tougher protections against AI-aided bioweapons
Some of the AI industry's biggest rivals have put their many, many grievances aside for a common cause: making it harder for people to use their technology to develop biological we…
The sculptor who brought us the blob-like babies is back – and the blobs have evolved
The acclaimed artist’s new commission for Science Gallery Melbourne is a call-back to her first hyperrealistic sculpture from 24 years ago.…
CRISPR Therapeutics AG (CRSP) Presents at Jefferies Global Healthcare Conference 2026 Transcript
CRISPR Therapeutics AG (CRSP) Jefferies Global Healthcare Conference 2026 June 3, 2026 9:55 AM EDTCompany ParticipantsSamarth Kulkarni - CEO &...…
OpenAI and Anthropic Sign Letter to Prevent AI-Developed Biological Weapons
Leading AI labs, executives, and scientists are sending a letter to lawmakers urging them to improve tracking of synthetic DNA sequences that could be used for bioweapons.…
The NIH Went to the Congo and All I Got Was This Lousy Monkeypox
This story has the makings of a James Bond film: communists, mad doctors spreading dangerous viruses, and globalist toilet people behind it all. And somewhere, I suspect, is a very…
Exelixis, Inc. (EXEL) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Exelixis, Inc. (EXEL) Jefferies Global Healthcare Conference 2026 June 3, 2026 11:05 AM EDTCompany ParticipantsAndrew Peters - Senior Vice President of...…
United Therapeutics Corporation (UTHR) Presents at Jefferies Global Healthcare Conference 2026 Transcript
United Therapeutics Corporation (UTHR) Jefferies Global Healthcare Conference 2026 June 3, 2026 12:45 PM EDTCompany ParticipantsJames Edgemond - CFO &...…
Qiagen N.V. (QGEN) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Qiagen N.V. (QGEN) Jefferies Global Healthcare Conference 2026 June 3, 2026 11:40 AM EDTCompany ParticipantsRoland Sackers - CFO, MD & Member of...…
Jazz Pharmaceuticals plc (JAZZ) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Jazz Pharmaceuticals plc (JAZZ) Jefferies Global Healthcare Conference 2026 June 3, 2026 10:30 AM EDTCompany ParticipantsRobert Iannone - Executive VP,...…
The Prognosis For Palvella Therapeutics
Palvella Therapeutics stock has surged, driven by strong results for its microcystic lymphatic malformations treatment. Read more on PVLA stock here.…
Bio-Rad Laboratories, Inc. (BIO) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Bio-Rad Laboratories, Inc. (BIO) Jefferies Global Healthcare Conference 2026 June 3, 2026 8:45 AM EDTCompany ParticipantsRoop Lakkaraju - Executive VP &...…
Tenaya Therapeutics, Inc. (TNYA) Discusses Interim Data from MyPEAK-1 Trial of TN-201 Gene Therapy for MYBPC3-Associated HCM Transcript
Tenaya Therapeutics, Inc. (TNYA) Discusses Interim Data from MyPEAK-1 Trial of TN-201 Gene Therapy for MYBPC3-Associated HCM June 3, 2026 8:00 AM EDTCompany...…
Veracyte, Inc. (VCYT) Presents at 46th Annual William Blair Growth Stock Conference - Slideshow
2026-06-03. The following slide deck was published by Veracyte, Inc.…
Tenaya Therapeutics, Inc. (TNYA) Discusses Interim Data from MyPEAK-1 Trial of TN-201 Gene Therapy for MYBPC3-Associated HCM - Slideshow
2026-06-03. The following slide deck was published by Tenaya Therapeutics, Inc.…
STAT+: Legend Biotech emerged as a rare market winner
New guidance for gene therapy developers, Lilly's deal for kidney drugs, and more biotech news from The Readout…
Celcuity: Selloff On Yesterday's Data Unwarranted - Buy Rating Upheld
Celcuity shares dropped over 25% despite Phase 3 VIKTORIA-1 data confirming gedatolisib's best-in-class efficacy. Click here to read more about the CELC stock.…
Legend Biotech Jumps 42% On New Data -- Here's What Comes Next
Buy Legend Biotech (LEGN): new Carvykti CARTITUDE-4 data show better survival and <1% Parkinsonism; upside at 3.0x EV/sales—read now.…
UBS raises Legend Biotech stock price target on NHL therapy outlook
TheraNyM Biologics opens ₹1,200 crore manufacturing facility near Hyderabad
TheraNyM Biologics opens a ₹1,200 crore facility near Hyderabad, with a potential to generate over 1,500 jobs…
Miami biotech executive was followed into his condo by man who allegedly threw him from 25th floor
A Miami biotech executive was followed into the skyscraper where he lived by the man, accused of pushing him off the building’s 25th floor, newly-released surveillance video shows.…
Capricor: I Rate It A Buy After Stress-Testing The Sell Thesis
Capricor (CAPR) speculative Buy ahead of Aug 22 PDUFA for deramiocel in DMD; HOPE-3 data reduces risk. Read here for a detailed analysis.…
The Unreasonable Redundancy of Nature's Protein Folds
A Ligo research note on redundancy in natural protein fold space and what kind of data still carries signal.…
Form 13D/A IO Biotech For: 2 June
BioVie Inc. (BIVI) Discusses Clinical Updates on Bezisterim and BIV201 for Parkinson's, Alzheimer's, and Ascites Transcript
BioVie Inc. (BIVI) Discusses Clinical Updates on Bezisterim and BIV201 for Parkinson's, Alzheimer's, and Ascites June 2, 2026 4:15 PM EDTCompany...…
STAT+: Pharmalittle: We’re reading about pancreatic and lung cancer drugs, China biotech growth, and more
Detailed study data for a pancreatic cancer treatment from Revolution Medicines confirmed it increased overall survival, from 13.2 months to 6.7 months…
STAT+: A turning point for pancreatic cancer patients
Eli Lilly announces two China deals, Akeso's lung cancer bispecific payoff, and more biotech news from The Readout…
Vericel Revenue Jumped 20%. One Biotech Investor Just Reported Adding $63 Million More
Vir Biotechnology, Inc. (VIR) Presents at EASL Congress 2026 - Slideshow
2026-05-30. The following slide deck was published by Vir Biotechnology, Inc.…
United Therapeutics Corporation (UTHR): Renaissance Technologies Likes This Biotech Stock
Dianthus Therapeutics: A Financed Autoimmune Platform With More Than One Way To Win
Dianthus Therapeutics is positioned as a category-expanding biotech, leveraging convenience and safety. Find out why DNTH stock is a buy.…
Novavax: The Pivot To A Royalty Model Is Working, But It's Still A Hold
Novavax (NVAX) shifts to a royalty-driven model with Sanofi and niche COVID/flu demand.…
Moderna, Inc. (MRNA) Presents at Bernstein 42nd Annual Strategic Decisions Conference Transcript
Moderna, Inc. (MRNA) Bernstein 42nd Annual Strategic Decisions Conference May 28, 2026 10:00 AM EDTCompany ParticipantsStéphane Bancel - CEO &...…
‘There is no way to stop this’: ‘Biotech Barbie’ Cathy Tie on her mission to genetically modify babies
The Canadian entrepreneur has always pushed the boundaries of gene editing, once attempting to turn horses into unicorns. Now she is set on modifying human embryos – something her …
STAT+: At ASCO, positive data for Bristol in multiple myeloma and Pfizer in lung cancer
You’re reading the web edition of ASCO in 30 Seconds, STAT’s guide to the American Society of Clinical Oncology annual meeting. Sign up for email editions…
Roivant Sciences Ltd. (ROIV) Presents at Bernstein 42nd Annual Strategic Decisions Conference Transcript
Roivant Sciences Ltd. (ROIV) Bernstein 42nd Annual Strategic Decisions Conference May 29, 2026 8:00 AM EDTCompany ParticipantsMatthew Gline - CEO &...…
Fortress Biotech: Is It Time To Pay The Deferred Preferred Stock Dividends?
Fortress Biotech now holds $256 million in cash and only $39 million in debt, establishing a fortress balance sheet. Read more on FBIO stock here.…
Vertex Pharmaceuticals Incorporated (VRTX) Presents at Bernstein 42nd Annual Strategic Decisions Conference Transcript
Vertex Pharmaceuticals Incorporated (VRTX) Bernstein 42nd Annual Strategic Decisions Conference May 29, 2026 9:00 AM EDTCompany ParticipantsReshma...…
Gilead Sciences, Inc. (GILD) Presents at Bernstein 42nd Annual Strategic Decisions Conference Transcript
Gilead Sciences, Inc. (GILD) Bernstein 42nd Annual Strategic Decisions Conference May 28, 2026 11:00 AM EDTCompany ParticipantsDaniel O'Day - Chairman &...…
Upstream Bio: The Reset Is The Opportunity, Initiating At Buy
Initiating a Buy rating on Upstream Bio, a small-cap biotech trading at an enterprise value under $200M. Click here to read my latest analysis of UPB stock.…
Pfizer is teaming up with a Chinese biotech on a $10.5 billion cancer drug deal
Form 6K Collplant Biotechnologies Ltd For: 29 May
Innovent Biologics shares rise 10% after pact with Pfizer of up to $10.5 billion
Innovent Biologics rose as much as 10%, after entering a strategic global licensing and collaboration agreement with Pfizer to develop oncology medicines.…
Personalis: Initiating Coverage Of Cancer Testing Biotech With A Buy Rating
Personalis, Inc. is rated Buy, driven by strong momentum in its NeXT Personal Dx MRD test and recent Medicare coverage expansions. Click for more on PSNL stock.…
GeoVax Labs, Inc. (GOVX) Discusses Building a Resilient Infectious Disease Preparedness Strategy Focused on Ebola, Marburg, Hantavirus, and Mpox Transcript
GeoVax Labs, Inc. (GOVX) Discusses Building a Resilient Infectious Disease Preparedness Strategy Focused on Ebola, Marburg, Hantavirus, and Mpox May 28,...…
Apogee Therapeutics: Charging Toward Pivotal Eczema Trial With Extended Dosing
Apogee Therapeutics, Inc. rated Buy: zumilokibart Phase 2b AD results, 2–4 doses/yr, Blackstone $1.3B funding; fair value $82.97—read now. Click for an APGE update.…
STAT+: Biotech veteran Jeremey Levin on why the industry’s future is secure, but American leadership is at risk
Biotech is producing scientific breakthroughs that once seemed impossible. But according to longtime industry executive Jeremy Levin, the institutions that support these advances, …
Enhanced Group: A Bet On Peptide And PED Overton Window Shift
The Enhanced Games, a massive marketing funnel for Enhanced Group, had a mixed inaugural event. Read more on ENHA stock here.…
Belite Bio, Inc (BLTE) Presents at 27th Fundus Disease Forum and International Retinal Symposium (Retina China 2026) - Slideshow
2026-05-27. The following slide deck was published by Belite Bio, Inc in conjunction with this event.…
Triomics nabs $22M to bring oncology-specific AI to cancer centers
The Series B round was led by Battery Ventures.…
Labor's CGT challenge deepens as biotech sector raises alarm
Another sector has called for a capital gains tax change carve-out, warning the government that it will face a talent drain without it.…